Logo image of NCL

NORTHANN CORP (NCL) Stock Fundamental Analysis

NYSEARCA:NCL - NYSE Arca - US66373M2008 - Common Stock - Currency: USD

0.2312  -0.03 (-12.79%)

After market: 0.2349 +0 (+1.6%)

Fundamental Rating

1

Taking everything into account, NCL scores 1 out of 10 in our fundamental rating. NCL was compared to 42 industry peers in the Building Products industry. Both the profitability and financial health of NCL have multiple concerns. NCL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NCL had negative earnings in the past year.
NCL had a negative operating cash flow in the past year.
NCL Yearly Net Income VS EBIT VS OCF VS FCFNCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M -4M -6M

1.2 Ratios

NCL's Return On Assets of -28.44% is on the low side compared to the rest of the industry. NCL is outperformed by 92.86% of its industry peers.
NCL's Return On Equity of -298.03% is on the low side compared to the rest of the industry. NCL is outperformed by 92.86% of its industry peers.
Industry RankSector Rank
ROA -28.44%
ROE -298.03%
ROIC N/A
ROA(3y)-14.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCL Yearly ROA, ROE, ROICNCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

Looking at the Gross Margin, with a value of 28.23%, NCL is doing worse than 61.90% of the companies in the same industry.
NCL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NCL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.86%
GM growth 5YN/A
NCL Yearly Profit, Operating, Gross MarginsNCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 -40

More info and screens

2

2. Health

2.1 Basic Checks

NCL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NCL has been reduced compared to 1 year ago.
NCL has a better debt/assets ratio than last year.
NCL Yearly Shares OutstandingNCL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M
NCL Yearly Total Debt VS Total AssetsNCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M

2.2 Solvency

NCL has an Altman-Z score of 0.38. This is a bad value and indicates that NCL is not financially healthy and even has some risk of bankruptcy.
NCL has a Altman-Z score of 0.38. This is amonst the worse of the industry: NCL underperforms 90.48% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that NCL is not too dependend on debt financing.
The Debt to Equity ratio of NCL (0.09) is better than 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACC9.83%
NCL Yearly LT Debt VS Equity VS FCFNCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M -4M

2.3 Liquidity

A Current Ratio of 0.53 indicates that NCL may have some problems paying its short term obligations.
NCL has a Current ratio of 0.53. This is amonst the worse of the industry: NCL underperforms 95.24% of its industry peers.
A Quick Ratio of 0.19 indicates that NCL may have some problems paying its short term obligations.
The Quick ratio of NCL (0.19) is worse than 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.19
NCL Yearly Current Assets VS Current LiabilitesNCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for NCL have decreased strongly by -41.49% in the last year.
Looking at the last year, NCL shows a very strong growth in Revenue. The Revenue has grown by 47.13%.
NCL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.19% yearly.
EPS 1Y (TTM)-41.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.03%
Revenue 1Y (TTM)47.13%
Revenue growth 3Y2.19%
Revenue growth 5YN/A
Sales Q2Q%18.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCL Yearly Revenue VS EstimatesNCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NCL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NCL Price Earnings VS Forward Price EarningsNCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCL Per share dataNCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NCL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NORTHANN CORP

NYSEARCA:NCL (6/12/2025, 8:14:43 PM)

After market: 0.2349 +0 (+1.6%)

0.2312

-0.03 (-12.79%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.54%
Inst Owner Change56.87%
Ins Owners42.63%
Ins Owner Change0%
Market Cap22.07M
AnalystsN/A
Price TargetN/A
Short Float %2.48%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.42
P/FCF N/A
P/OCF N/A
P/B 15.89
P/tB 60.35
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.16
BVpS0.01
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.44%
ROE -298.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.23%
FCFM N/A
ROA(3y)-14.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.86%
GM growth 5YN/A
F-Score5
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.19
Altman-Z 0.38
F-Score5
WACC9.83%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)47.13%
Revenue growth 3Y2.19%
Revenue growth 5YN/A
Sales Q2Q%18.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-455.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.39%
OCF growth 3YN/A
OCF growth 5YN/A